Drug Shortage Report for PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD
Report ID | 83325 |
Drug Identification Number | 02243737 |
Brand name | PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD |
Common or Proper name | PHENTOLAMINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PHENTOLAMINE MESYLATE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10X1ml |
ATC code | C04AB |
ATC description | PERIPHERALVASODILATORS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-04-29 |
Estimated end date | 2019-10-07 |
Actual end date | 2019-09-19 |
Shortage status | Resolved |
Updated date | 2019-10-15 |
Company comments | Competitive BO resulting in limited supply. Closely monitoring stock at wholesalers. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-05-07 | English | Compare |
v2 | 2019-05-07 | French | Compare |
v3 | 2019-09-10 | English | Compare |
v4 | 2019-09-10 | French | Compare |
v5 | 2019-10-15 | English | Compare |
v6 | 2019-10-15 | French | Compare |
Showing 1 to 6 of 6